ArticleFrontiers in aging neuroscience2022
3D FRN-ResNet: An Automated Major Depressive Disorder Structural Magnetic Resonance Imaging Data Identification Framework.
Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- 3DViT-GAT: a unified atlas-based 3D vision transformer and graph learning framework for major depressive disorder detection using structural MRI data.Scientific reports · 2026Article
- Association between miR-182 rs76481776 Polymorphism and Antidepressant Treatment Response in Patients with Depression.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026Article
- Detecting schizophrenia with 3D structural brain MRI using deep learning.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major Depressive Disorder (MDD) is the most prevalent psychiatric disorder, seriously affecting people's quality of life. Manually identifying MDD from structural magnetic resonance imaging (sMRI) images is laborious and time-consuming due to the lack of clear physiological indicators. With the development of deep learning, many automated identification methods have been developed, but most of them stay in 2D images, resulting in poor performance. In addition, the heterogeneity of MDD also results in slightly different changes reflected in patients' brain imaging, which constitutes a barrier to the study of MDD identification based on brain sMRI images. We propose an automated MDD identification framework in sMRI data (3D FRN-ResNet) to comprehensively address these challenges, which uses 3D-ResNet to extract features and reconstruct them based on feature maps. Notably, the 3D FRN-ResNet fully exploits the interlayer structure information in 3D sMRI data and preserves most of the spatial details as well as the location information when converting the extracted features into vectors. Furthermore, our model solves the feature map reconstruction problem in closed form to produce a straightforward and efficient classifier and dramatically improves model performance. We evaluate our framework on a private brain sMRI dataset of MDD patients. Experimental results show that the proposed model exhibits promising performance and outperforms the typical other methods, achieving the accuracy, recall, precision, and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.